Showing results (61-70 of 170) with videos related to

Sort By:
Pageof 17
JAMA Oncology|December 30, 2016
Second Opinions From Medical Oncologists for Early-Stage Breast Cancer: Prevalence, Correlates, and ConsequencesAllison W Kurian, Christopher R Friese, Irina Bondarenko, et al.
JAMA Otolaryngology-- Head & Neck Surgery|December 23, 2020
Physician Confidence in Neck Ultrasonography for Surveillance of Differentiated Thyroid Cancer RecurrenceKevin J Kovatch, David Reyes-Gastelum, Jennifer A Sipos, et al.
Urologic Oncology|May 21, 2014
Association of reimbursement policy and urologists' characteristics with the use of medical androgen deprivation therapy for clinically localized prostate cancerRuben G W Quek, Viraj A Master, Kenneth M Portier, et al.
JAMA Oncology|June 7, 2017
Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical ManagementMonica Morrow, Paul Abrahamse, Timothy P Hofer, et al.
Contemporary Clinical Trials Communications|November 21, 2017
Study protocol: A Randomized Controlled Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool (iCanDecide)Sarah T Hawley, Yun Li, L Alexandra Jeanpierre, et al.
Leukemia & Lymphoma|November 11, 2016
Patterns of use and survival outcomes of positron emission tomography for initial staging in elderly follicular lymphoma patientsAshish Rai, Loretta J Nastoupil, Jessica N Williams, et al.
Cancer|November 8, 2018
Pregnancy after cancer: Does timing of conception affect infant health?Kathleen P Hartnett, Ann C Mertens, Michael R Kramer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Association between urologist characteristics and radiation oncologist consultation for patients with locoregional prostate cancerRuben G W Quek, Kevin C Ward, Viraj A Master, et al.
Nutrition and Cancer|September 13, 2006
Lycopene intake and prostate cancer risk: effect modification by plasma antioxidants and the XRCC1 genotypeMichael Goodman, Roberd M Bostick, Kevin C Ward, et al.
Cancer|August 6, 2013
Determinants of the combined use of external beam radiotherapy and brachytherapy for low-risk, clinically localized prostate cancerRuben G W Quek, Viraj A Master, Kevin C Ward, et al.
Pageof 17